Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


Pulmonary hypertension and chronic lung disease: where are we headed?

Elia D, Caminati A, Zompatori M, Cassandro R, Lonati C, Luisi F, Pelosi G, Provencher S, Harari S.

Eur Respir Rev. 2019 Oct 21;28(153). pii: 190065. doi: 10.1183/16000617.0065-2019. Print 2019 Sep 30. Review.


Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue.

Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O, Zompatori M, Uslenghi E, Harari S.

Eur Respir Rev. 2019 Oct 1;28(153). pii: 190044. doi: 10.1183/16000617.0044-2019. Print 2019 Sep 30. Review.


Unusual presentation of acute pulmonary hypertension in a patient with bilateral pneumonia and hypertrophic cardiomyopathy.

Sonaglioni A, Lombardo M, Rigamonti E, Vincenti A, Nicolosi GL, Trevisan R, Zompatori M, Cassandro R, Harari S, Anzà C.

J Cardiovasc Med (Hagerstown). 2019 Dec;20(12):853-856. doi: 10.2459/JCM.0000000000000848. No abstract available.


Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography.

Sonaglioni A, Baravelli M, Cassandro R, Torre O, Elia D, Anzà C, Harari S.

J Am Soc Echocardiogr. 2018 Aug;31(8):888-901. doi: 10.1016/j.echo.2018.02.004. Epub 2018 Mar 28.


Physiological insights of exercise hyperventilation in arterial and chronic thromboembolic pulmonary hypertension.

Farina S, Bruno N, Agalbato C, Contini M, Cassandro R, Elia D, Harari S, Agostoni P.

Int J Cardiol. 2018 May 15;259:178-182. doi: 10.1016/j.ijcard.2017.11.023.


Severe idiopathic pulmonary fibrosis: what can be done?

Caminati A, Cassandro R, Torre O, Harari S.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170047. doi: 10.1183/16000617.0047-2017. Print 2017 Sep 30. Review.


The ATS/JRS Guidelines on Lymphangioleiomyomatosis: Filling in the Gaps.

Harari S, Cassandro R, Torre O.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):659-660. doi: 10.1164/rccm.201702-0272LE. No abstract available.


The changing face of a rare disease: lymphangioleiomyomatosis.

Harari S, Torre O, Cassandro R, Moss J.

Eur Respir J. 2015 Nov;46(5):1471-85. doi: 10.1183/13993003.00412-2015. Epub 2015 Sep 24. Review.


Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.

Elia D, Torre O, Cassandro R, Caminati A, Harari S.

Eur J Intern Med. 2015 Jun;26(5):351-6. doi: 10.1016/j.ejim.2015.04.001. Epub 2015 Apr 17. Review.


Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.

Harari S, Caminati A, Cassandro R, Conti S, Madotto F, Luisi F, Cesana G.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):297-305.


Pulmonary hypertension in chronic interstitial lung diseases.

Caminati A, Cassandro R, Harari S.

Eur Respir Rev. 2013 Sep 1;22(129):292-301. doi: 10.1183/09059180.00002713. Review.


Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis.

Harari S, Torre O, Cassandro R, Taveira-DaSilva AM, Moss J.

Respir Med. 2012 Sep;106(9):1286-92. doi: 10.1016/j.rmed.2012.06.012. Epub 2012 Jul 7.


Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes.

Calabrò E, Randi G, La Vecchia C, Sverzellati N, Marchianò A, Villani M, Zompatori M, Cassandro R, Harari S, Pastorino U.

Eur Respir J. 2010 Jan;35(1):146-51. doi: 10.1183/09031936.00049909. Epub 2009 Aug 13.


Reversible airflow obstruction in lymphangioleiomyomatosis.

Taveira-DaSilva AM, Steagall WK, Rabel A, Hathaway O, Harari S, Cassandro R, Stylianou M, Moss J.

Chest. 2009 Dec;136(6):1596-1603. doi: 10.1378/chest.09-0624. Epub 2009 May 15. Erratum in: Chest. 2010 Mar;137(3):744.


Bosentan for patients with chronic thromboembolic pulmonary hypertension.

Vassallo FG, Kodric M, Scarduelli C, Harari S, Potena A, Scarda A, Piattella M, Cassandro R, Confalonieri M.

Eur J Intern Med. 2009 Jan;20(1):24-9. doi: 10.1016/j.ejim.2008.03.008. Epub 2008 Apr 29.


Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.

Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S.

Respir Med. 2009 Jan;103(1):117-23. doi: 10.1016/j.rmed.2008.07.022. Epub 2008 Sep 10.


Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

Harari S, Cassandro R, Chiodini I, Taveira-DaSilva AM, Moss J.

Chest. 2008 Feb;133(2):448-54. Epub 2007 Dec 10. Erratum in: Chest. 2009 Aug 1;136(2):653. Chiodini, Jacopo [corrected to Chiodini, Iacopo].


Pulmonary arterial hypertension secondary to chronic lung diseases: pathogenesis and medical treatment.

Cassandro R, Harari S.

Sarcoidosis Vasc Diffuse Lung Dis. 2006 Oct;23(3):163-79. Review.


Local control and distant metastasis after electrochemotherapy of a canine anal melanoma.

Spugnini EP, Filipponi M, Romani L, Dotsinsky I, Mudrov N, Baroni A, Ruocco E, Laieta MT, Montesarchio V, Cassandro R, Citro G, Baldi A.

In Vivo. 2007 Sep-Oct;21(5):897-9.


Down-regulation of aquaporin 4 in human placenta throughout pregnancy.

De Falco M, Cobellis L, Torella M, Acone G, Varano L, Sellitti A, Ragucci A, Coppola G, Cassandro R, Laforgia V, Varano L, De Luca A.

In Vivo. 2007 Sep-Oct;21(5):813-7.


Modulation of Bax expression in physiological and pathological human placentas throughout pregnancy.

Cobellis L, De Falco M, Torella M, Trabucco E, Caprio F, Federico E, Manente L, Coppola G, Laforgia V, Cassandro R, Colacurci N, De Luca A.

In Vivo. 2007 Sep-Oct;21(5):777-83.


Analysis of HtrA1 serine protease expression in human lung cancer.

Esposito V, Campioni M, De Luca A, Spugnini EP, Baldi F, Cassandro R, Mancini A, Vincenzi B, Groeger A, Caputi M, Baldi A.

Anticancer Res. 2006 Sep-Oct;26(5A):3455-9.


Effects of indinavir in a preliminary phase I study on dogs with stage III slenic hemangiosarcoma.

Spugnini EP, Esposito V, Groeger AM, Cassandro R, Onori N, Chirianni A, Baldi A.

In Vivo. 2006 Jan-Feb;20(1):125-7.


Spontaneous intestinal melanoma in dogs.

Spugnini EP, Dragonetti E, Murace R, Cassandro R, Groeger AM, Di Marino M, Baldi A.

In Vivo. 2005 Nov-Dec;19(6):1051-4.


A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.

Santini D, Vincenzi B, La Cesa A, Virzi V, Navajas F, Malafarina V, Dicuonzo G, Cassandro R, Esposito V, Montesarchio V, Groeger AM, Tonini G.

Anticancer Res. 2005 Jan-Feb;25(1B):669-74.


Pleomorphic lipoma: a definite histopathological entity.

Persichetti P, Di Lella F, Marangi GF, Cagli B, Simone P, Tenna S, Rabitri C, Cassandro R, Esposito V, Groeger AM, Baldi A.

Anticancer Res. 2004 Sep-Oct;24(5B):3157-9.


Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers.

Groeger AM, Esposito V, De Luca A, Cassandro R, Tonini G, Ambrogi V, Baldi F, Goldfarb R, Mineo TC, Baldi A, Wolner E.

Histopathology. 2004 Jan;44(1):54-63.


Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival.

Baldi A, Groeger AM, Esposito V, Cassandro R, Tonini G, Battista T, Di Marino MP, Vincenzi B, Santini M, Angelini A, Rossiello R, Baldi F, Paggi MG.

Thorax. 2002 Apr;57(4):353-6.


A model of BAX gene delivery to human lung cancer.

Groeger AM, Esposito V, Cassandro R, Baldi G, Rossiello L, De Luca L, Kadletz M, Kaiser HE.

Anticancer Res. 2001 Sep-Oct;21(5):3627-30.


Evidence of a restrictive spirometric pattern in older thalassemic patients.

Filosa A, Esposito V, Meoli I, Stefanelli F, Cassandro R.

Respiration. 2001;68(3):273-8.


Supplemental Content

Loading ...
Support Center